Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT06670079

Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients

Led by University of Vermont · Updated on 2026-05-13

30

Participants Needed

1

Research Sites

76 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if a treatment for adults with PTSD called prolonged exposure + incentives (PE+) works to treat pregnant patients. The main question it aims to answer is: Does PE+ decrease PTSD symptoms? All participants will receive PE+ to see if their PTSD symptoms at the end of the trial are less than at the beginning. Participants will: * Receive individual PE+ therapy for 1 hour weekly for 12 weeks. * Receive financial incentives for attending each PE+ session. * Attend assessment visits every 4 weeks for the 12 weeks of the trial. * Allow research staff to collect some information about their labor and delivery from their medical records after their babies are born.

CONDITIONS

Official Title

Prolonged Exposure Therapy to Treat Posttraumatic Stress Disorder in Pregnant Patients

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female
  • Older than 18 years
  • Pregnant with gestational age 25 weeks or less
  • Meet DSM-5 criteria for PTSD based on the Clinician Administered PTSD Scale for DSM-5
  • If taking psychotropic medications, must be on a stable dose for more than 14 days before joining
Not Eligible

You will not qualify if you...

  • Male
  • Younger than 18 years
  • Pregnant with gestational age greater than 25 weeks
  • No current PTSD diagnosis
  • Experiencing delusions or hallucinations, unstable bipolar disorder, or imminent suicide risk as assessed by the Mini International Neuropsychiatric Interview
  • Currently enrolled in another evidence-based PTSD treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University of Vermont

Burlington, Vermont, United States, 05401

Actively Recruiting

Loading map...

Research Team

K

Kelly Peck, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here